Clinical trial
Special Drug Use Investigation of EYLEA for Diabetic Macular Edema
NCT02425501 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation of EYLEA for Diabetic Macular Edema
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 20, 2015
- Completion date
- August 13, 2019
- Enrollment
- 646 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.